XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.2
License Agreements and Acquired Patent Applications (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jan. 13, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
License Agreements and Acquired Patent Applications [Line Items]              
Research and development expenses   $ 4,896   $ 10,577 $ 1,258,208 $ 13,389  
Issuance of common stock (in Shares)   88,312     96,641    
Aggregate purchase price   $ 66,101 $ 1,441,964        
Common shares value $ 850,500 1,323     $ 1,323   $ 804
Price per share (in Dollars per share) $ 1.89            
Patent Application Acquisition Agreement [Member]              
License Agreements and Acquired Patent Applications [Line Items]              
Research and development expenses   0     1,250,500    
Cash payment $ 400,000            
Issuance of common stock (in Shares) 450,000            
Fair value of common stock $ 850,500            
Aggregate purchase price 1,250,500            
Common shares value $ 850,500            
Price per share (in Dollars per share) $ 1.89            
Chelexa Biosciences, Inc. and the University of Cincinnati [Member]              
License Agreements and Acquired Patent Applications [Line Items]              
Research and development expenses   2,708   417 3,333 417  
The George Washington University [Member]              
License Agreements and Acquired Patent Applications [Line Items]              
Research and development expenses   1,250   8,597 2,500 9,847  
North Carolina State University [Member]              
License Agreements and Acquired Patent Applications [Line Items]              
Research and development expenses   $ 938   1,563 $ 1,875 3,125  
Warrants [Member] | The George Washington University [Member]              
License Agreements and Acquired Patent Applications [Line Items]              
Research and development expenses       $ 6,389   $ 6,389